Evidence map›Paper›PMID 28435268›Full record

ArticleInternational journal of nanomedicine2017

Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability.

Juntao Yin, Cuiyu Xiang, Peiqing Wang, Yuyun Yin, Yantao Hou

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. The Flavonoid Components ofCurrent topics in medicinal chemistry · 2023
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Whey Proteins as a Potential Co-Surfactant withMolecules (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. International journal of molecular sciences · 2021
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Juntao YinDepartment of Pharmaceutics, Huaihe Hospital Affiliated to Henan University, Kaifeng.
Cuiyu XiangDepartment of Pharmaceutics, Huaihe Hospital Affiliated to Henan University, Kaifeng.
Peiqing WangDepartment of Pharmaceutics, Huaihe Hospital Affiliated to Henan University, Kaifeng.
Yuyun YinDepartment of Physiochemical Analysis, Henan Provincial Institute for Food and Drug Control, Zhengzhou.
Yantao HouDepartment of Pharmaceutical Engineering, Henan Vocational College of Applied Technology, Kaifeng, People's Republic of China.
Henan University Huaihe Hospital and Huaihe Clinical Institute · CNHenan Forestry Vocational College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Baicalein (BCL) possesses high pharmacological activities but low solubility and stability in the intestinal tract. This study aimed to probe the potential of nanoemulsions (NEs) consisting of hemp oil and less surfactants in ameliorating the oral bioavailability of BCL. BCL-loaded NEs (BCL-NEs) were prepared by high-pressure homogenization technique to reduce the amount of surfactants. BCL-NEs were characterized by particle size, entrapment efficiency (EE), in vitro drug release, and morphology. Bioavailability was studied in Sprague-Dawley rats following oral administration of BCL suspensions, BCL conventional emulsions, and BCL-NEs. The obtained NEs were ~90 nm in particle size with an EE of 99.31%. BCL-NEs significantly enhanced the oral bioavailability of BCL, up to 524.7% and 242.1% relative to the suspensions and conventional emulsions, respectively. BCL-NEs exhibited excellent intestinal permeability and transcellular transport ability. The cytotoxicity of BCL-NEs was documented to be low and acceptable for oral purpose. Our findings suggest that such novel NEs and preparative process provide a promising alternative to current formulation technologies and suitable for oral delivery of drugs with bioavailability issues.

Indexed as

Administration, OralAnimalsBiological AvailabilityCaco-2 CellsCannabisEmulsionsFlavanonesHumansIntestinal AbsorptionParticle SizePlant OilsRatsRats, Sprague-DawleySolubilitySurface-Active AgentsbaicaleinEmulsionsFlavanonesPlant OilsSurface-Active Agentsbaicaleinbioavailabilitybiocompatibilityhemp oilhigh-pressure homogenizationnanoemulsions

Identifiers

PMID28435268
PMCPMC5391827
OpenAlexW2606059474

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.